FiercePharmaAsia—Takeda’s Velcade patent, Sinovac’s delisting drama, Samsung-Biogen’s Humira biosim
admin 30th June 2017 Uncategorised 0Takeda is asking the FDA to hold off on approving copies of its Velcade, Sinovac’s take-private process takes a turn as a new bid emerges, Samsung and Biogen’s Humira copycat gets EMA recommendation.
More: FiercePharmaAsia—Takeda’s Velcade patent, Sinovac’s delisting drama, Samsung-Biogen’s Humira biosim
Source: fierce